NTLAIntellia Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Intellia Therapeutics, Inc. against ARK Innovation ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLAEsta | $1.5B#15 | — | 2.4x#3 | 22.5x#13 | 16.9%#11 | 20.5%#8 | -651.7%#15 | -66.5%#15 | — | — | -13.0%#7 | — |
| TSLA | $1.17T#2 | 273.9x#8 | 13.4x#13 | 12.3x#7 | -2.9%#15 | -46.5%#13 | 4.6%#7 | 4.4%#7 | 4.3%#4 | 5#2 | -7.9%#5 | — |
| TEM | $8M#16 | — | 0.0x#1 | 0.0x#1 | 83.4%#4 | 65.3%#5 | -19.9%#10 | -58.8%#14 | — | — | -26.3%#10 | — |
| AMD | $692.5B#3 | 139.2x#7 | 10.7x#11 | 20.0x#12 | 34.3%#8 | 164.2%#3 | 10.7%#6 | 6.7%#6 | 6.0%#3 | 7#1 | 139.4%#2 | — |
| CRSP | $4.6B#13 | — | 2.5x#4 | 1307.1x#16 | -90.6%#16 | -58.8%#15 | -18933.6%#16 | -32.1%#13 | -33.6%#6 | — | -19.4%#8 | — |
| SHOP | $169.8B#5 | 127.7x#5 | 13.6x#14 | 14.7x#9 | 30.1%#9 | -39.0%#12 | 12.7%#4 | 9.8%#4 | — | — | 4.4%#3 | — |
| ROKU | $21.3B#10 | 106.6x#4 | 8.0x#9 | 4.5x#3 | 15.2%#12 | 168.3%#2 | -0.1%#8 | 3.3%#8 | — | — | — | — |
| HOOD | $83.4B#6 | 45.0x#2 | 9.7x#10 | 18.6x#10 | 51.6%#6 | 33.5%#7 | 47.1%#1 | 22.0%#1 | — | — | -10.2%#6 | — |
| COIN | $44.2B#7 | 61.7x#3 | 3.3x#5 | 6.2x#4 | 9.4%#14 | -50.0%#14 | 20.0%#3 | 9.6%#5 | 12.2%#2 | — | -54.8%#12 | — |
| CRCL | $15.0B#11 | — | 4.4x#6 | 136.8x#15 | 624.0%#1 | -144.7%#16 | -87.8%#13 | -2.0%#9 | — | — | -66.1%#13 | — |
| PLTR | $296.1B#4 | 138.8x#6 | 35.0x#15 | 66.2x#14 | 56.2%#5 | 251.6%#1 | 31.6%#2 | 19.2%#3 | — | — | -21.0%#9 | — |
| RBLX | $35.4B#9 | — | 82.0x#16 | 7.2x#6 | 35.8%#7 | -13.9%#10 | -25.2%#11 | -248.1%#16 | -489.0%#9 | — | — | — |
| BEAM | $2.7B#14 | — | 2.3x#2 | 19.3x#11 | 120.0%#3 | 78.8%#4 | -274.6%#14 | -6.9%#10 | -39.3%#7 | — | — | — |
| TWST | $5.5B#12 | — | 12.1x#12 | 14.7x#8 | 20.3%#10 | 62.8%#6 | -36.2%#12 | -17.1%#11 | -40.9%#8 | — | 155.5%#1 | — |
| CRWV | $35.5B#8 | — | 7.5x#8 | 6.9x#5 | 167.9%#2 | -35.3%#11 | -0.9%#9 | -24.5%#12 | -0.2%#5 | — | -38.1%#11 | — |
| AMZN | $2.44T#1 | 27.1x#1 | 5.5x#7 | 3.4x#2 | 12.4%#13 | 16.9%#9 | 11.2%#5 | 20.5%#2 | 14.0%#1 | 5#2 | -1.9%#4 | — |
Peer set: top holdings of ARKK (ARK Innovation ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-07-29.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice